Biotage AB (BIOT):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME5969FSA
◆発行会社(調査会社):GlobalData
◆発行日:2014年10月28日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Biotage AB (BIOT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biotage AB (Biotage) is a biotechnology company. It provides comprehensive solutions in the field of medicinal and analytical chemistry, peptide synthesis, separation, and purification. The company is a global service provider of instruments, reagents and service to pharmaceutical and biotechnological companies and academic institutions. Biotage offers products under three categories, namely, Organic Chemistry, Analytical Chemistry and Industrial Resins. Its major products include microwave instruments such as Biotage Initrieator +, Biotage Initiator Classic, and Biotage Advancer; industrial resins such as Resna, and molecularly imprinted polymers (MIPs);sample preparation instruments such as Biotage Extrahera, Biotage Pressure, Biotage VacMaster 10 and 20, and RapidTrace among others; flash purification cartridges and systems; and reaction screening instruments. The company has wholly owned subsidiaries in Sweden, the UK, Germany, France, Switzerland, Italy, the US and Japan and offers its products across the world. Biotage is headquartered in Uppsala, Sweden.

Biotage AB Key Recent Developments

Oct 01, 2014: New Automated Sample Preparation System
Jul 01, 2014: New Application: Effective Extraction of Vitamin D Metabolites Utilizing ISOLUTE SLE
Jun 30, 2014: Biotage Launches ACI – Accelerated Chromatographic Isolation
Jun 17, 2014: New 1 mL ISOLUTE SLE+ 48-well Plates from Biotage – Extract Larger Sample Volumes, Faster
Feb 13, 2014: Biotage Reports Year-End Report for 2013

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 – About the Company 6
Biotage AB – Key Facts 6
Biotage AB – Key Employees 7
Biotage AB – Key Employee Biographies 8
Biotage AB – Major Products and Services 9
Biotage AB – History 11
Biotage AB – Company Statement 14
Biotage AB – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Biotage AB – Key Manufacturing Facilities 17
Section 2 – Company Analysis 18
Biotage AB – Business Description 18
Biotage AB – Corporate Strategy 19
Biotage AB – SWOT Analysis 20
SWOT Analysis – Overview 20
Biotage AB – Strengths 20
Strength – Focused Research and Development Activities 20
Strength – Strong Geographical Presence 20
Strength – Strong Customer Base 20
Biotage AB – Weaknesses 22
Weakness – Weak Liquidity Position 22
Weakness – Weakened Operational Performance 22
Weakness – Product Discontinuation 22
Biotage AB – Opportunities 23
Opportunity – Growing Aged Population 23
Opportunity – New Manufacturing Plant 23
Opportunity – New Product Launches 23
Biotage AB – Threats 24
Threat – Competition and Technological Change 24
Threat – Stringent Governmental Regulations 24
Threat – Changing Diagnostic Market Conditions 24
Biotage AB – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
Section 4 – Company’s Lifesciences Financial Deals and Alliances 32
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 32
Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 33
Biotage AB, Medical Equipment, Deals By Year, 2008 to YTD 2014 34
Biotage AB, Medical Equipment, Deals By Type, 2008 to YTD 2014 35
Biotage AB, Recent Deals Summary 36
Section 5 – Company’s Recent Developments 37
Jun 30, 2014: Biotage Launches ACI – Accelerated Chromatographic Isolation 37
Feb 13, 2014: Biotage Reports Year-End Report for 2013 38
Nov 08, 2013: New Manufacturing Plant Opens in Ystrad Mynach 40
Oct 25, 2013: Biotage: Interim Report for the Period January – September 2013 41
Aug 15, 2013: Biotage Announces Interim report for the period January – June 2013 43
Jan 16, 2013: Biotage Receives Positive Ruling From US Patent and Trademark Office’s Patent Trial And Appeal Board In Re-examination Proceedings 45
Section 6 – Appendix 46
Methodology 46
Ratio Definitions 46
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Biotage AB, Key Facts 6
Biotage AB, Key Employees 7
Biotage AB, Key Employee Biographies 8
Biotage AB, Major Products and Services 9
Biotage AB, History 11
Biotage AB, Other Locations 15
Biotage AB, Subsidiaries 15
Biotage AB, Key Manufacturing Facilities 17
Biotage AB, Key Competitors 25
Biotage AB, Ratios based on current share price 26
Biotage AB, Annual Ratios 27
Biotage AB, Interim Ratios 30
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 32
Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 33
Biotage AB, Medical Equipment, Deals By Year, 2008 to YTD 2014 34
Biotage AB, Medical Equipment, Deals By Type, 2008 to YTD 2014 35
Biotage AB, Recent Deals Summary 36
Currency Codes 46
Capital Market Ratios 46
Equity Ratios 47
Profitability Ratios 47
Cost Ratios 48
Liquidity Ratios 48
Leverage Ratios 49
Efficiency Ratios 49

List of Figures
Biotage AB, Performance Chart (2009 - 2013) 29
Biotage AB, Ratio Charts 31
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 32
Biotage AB, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 33
Biotage AB, Medical Equipment, Deals By Year, 2008 to YTD 2014 34
Biotage AB, Medical Equipment, Deals by Type, 2008 to YTD 2014 35

★調査レポート[Biotage AB (BIOT):企業概要、財務及び戦略的SWOT分析] (コード:GDME5969FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Biotage AB (BIOT):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆